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Enterohemorrhagic Escherichia coli (EHEC), a subset of Shiga toxin producing E. coli
(STEC) is associated with a spectrum of diseases that includes diarrhea, hemorrhagic
colitis and a life-threatening hemolytic-uremic syndrome (HUS). Regardless of serotype,
Shiga toxins (Stx1 and/or Stx2) are uniformly expressed by all EHEC, and so exploitable
targets for laboratory diagnosis of these pathogens. In this study, a sandwich ELISA for
determination of Shiga toxin (Stx) was developed using anti-Stx2B subunit antibodies
and its performance was compared with that of the Vero cell assay and a commercial
immunoassay kit. Chicken IgY was used as capture antibody and a HRP-conjugated rabbit
IgG as the detection antibody. The anti-Stx2B IgY was harvested from eggs laid by hens
immunized with a recombinant protein fragment. Several parameters were tested in order
to optimize the sandwich ELISA assay, including concentration of antibodies, type and
concentration of blocking agent, and incubation temperatures. Supernatants from 42 STEC
strains of different serotypes and stx variants, including stx2EDL933, stx2vha, stx2vhb, stx2g,
stx1EDL933, and stx1d were tested. All Stx variants were detected by the sandwich ELISA,
with a detection limit of 115 ng/ml Stx2. Twenty three strains negative for stx genes,
including different bacteria species, showed no activity in Vero cell assay and produced
negative results in ELISA, except for two strains. Our results show that anti-Stx2B IgY
sandwich ELISA could be used in routine diagnosis as a rapid, specific and economic
method for detection of Shiga toxin-producing E. coli.
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INTRODUCTION
Enterohemorrhagic Escherichia coli (EHEC) causes a spectrum
of human diseases ranging from mild non-bloody diarrhea
through hemorrhagic colitis to the extraintestinal manifestation
hemolytic-uremic syndrome (HUS) (Griffin and Tauxe, 1991).
The incidence of HUS in Argentina is one of the highest in the
world, with approximately 500 new cases being observed each
year in under-5-year-old children (Rivas et al., 2010). Also, it is
the leading cause of acute renal failure in pediatric age and the
second for chronic renal failure (Exeni, 2001). Prompt and accu-
rate diagnosis of Shiga toxin producing E. coli (STEC) infection is
important to achieve an appropriate and early supportive treat-
ment in the course of infection to decrease renal damage and
improve overall patient outcome (Ake et al., 2005).
Shiga toxins (Stxs) are thought to be the major virulence factor
of STEC strains (Tarr et al., 2005) and comprise a family com-
posed of Stx1, Stx2, and their variants, which can be found in
STEC strains isolated from either humans or animals (Ito et al.,
1990). Stx2, which is 56% homologous to Stx1 at the amino acid
sequence level, is clinically the most important Stx type, because
it is associated with severe outcomes of human infections includ-
ing HUS (Friedrich et al., 2002; Brooks et al., 2005). Stxs consist
of a single A subunit, with catalytic activity, linked to a ring of
five B subunits, responsible for specific cell binding of the toxin
(O’Brien and Holmes, 1987).
The expression of Stx is characteristic of STEC strains and so,
exploitable targets for laboratory diagnosis of these pathogens.
Numerous assays for the diagnosis of STEC have been devel-
oped including microbiological, immunological, and genetical
methods (Bettelheim and Beutin, 2003). Cytotoxicity assays are
the most sensitive methods for detecting active Stxs (Paton and
Paton, 1998) and have been used as “gold standard” for evalua-
tion of immunological tests. However, this technique is expensive,
labor-intensive, and time consuming and so, not often established
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for routine diagnosis. Stx-specific PCR detects gene sequences
whether or not they are expressed (Bettelheim and Beutin, 2003).
Stx-specific ELISA is a rapid, easy to perform and applicable
technique for routine diagnosis, with a growing number of Stx-
detection test kits offered by several companies (Scheutz et al.,
2001). Compared to cytotoxicity assays or PCR, ELISAs are less
sensitive (Beutin et al., 1996, 1997; Gerritzen, 1998) and not suit-
able to evaluate samples where low amounts of Stx are expected,
such as mixed cultures and certain Stx2 variants (Ball et al., 1996;
Beutin et al., 1996, 2007). These commercial kits are also econom-
ically unaffordable for use in developing countries. A lower cost
alternative are ELISA assays based on the use of egg yolk anti-
bodies (IgY) from laying hens and obtained in a non-invasive
way. IgY is the typical low-molecular-weight egg yolk antibody
of birds, reptiles, amphibians, and lungfish, whereas IgG occurs
in mammals (Hardin et al., 2001). Because of the evolutionary
distance between birds and mammals, a chicken is often a bet-
ter choice for antibody production than a mammal when the
antigen is of human or other mammalian origin (Schade et al.,
2005). IgY also has the advantage to avoid the interference caused
by the complement system, rheumatoid factors, anti-mouse IgG
antibodies or human and bacterial Fc receptors in immunolog-
ical assays. In addition, there is a minimal or no cross-reaction
with mammalian IgG (Ambrosius and Hadge, 1987; Larsson and
Sjoquist, 1990). Therefore, this study was intended to develop a
sandwich ELISA using IgY as the capture antibody and a rabbit
IgG as the detection antibody for determination of Shiga tox-
ins in culture supernatants as a potential affordable research and
diagnostic tool.
MATERIALS AND METHODS
PRODUCTION OF RECOMBINANT Stx2B
Stx2B subunit was produced as previously described (Parma et al.,
2011). Briefly, a DNA fragment encoding Stx2B was obtained by
PCR amplification using DNA extracted from the reference strain
E. coli EDL933. For expression of recombinant Stx2B subunit,
transformed BL21–AI™ E. coli cells were grown in Luria-Bertani
(LB) broth supplemented with 100μg/mL ampicillin (Sigma
Aldrich) and induced overnight with 0.2% L (+) arabinose
(Sigma Aldrich). The Stx2B was purified by affinity chromatog-
raphy using a Ni-NTA column (Qiagen). The purity and identity
of the protein was checked by SDS-PAGE and Western blotting,
respectively. The protein content was determined by Bradford
assay using BSA as the standard protein.
PREPARATION OF Stx2-SPECIFIC IgY AND IgG ANTIBODIES
Anti-Stx2 polyclonal IgY and IgG antibodies were obtained as
described in Parma et al. (2011) by immunization of hens and
rabbits with recombinant Stx2B. This procedure was reviewed by
the Animal Care and Use Committee at The National Institute of
Agriculture Technology. Briefly, the egg yolk was physically sep-
arated from the egg white and mixed with four volumes of cold
distilled water and kept at −20◦C for at least 72 h and there-
after thawed at 4◦C. The disrupted emulsion was centrifuged
at 8000 × g, 15min at 4◦C. The liquid phase containing the
IgY was filtered through a gauze tissue and ammonium sul-
phate was added (0.24 g/ml supernatant). After centrifugation at
10,000 × g, 15min at 4◦C, the pellet was dissolved with ammo-
nium sulphate 2M and centrifuged again. Finally, the pellet was
resuspended and dialyzed against PBS (pH 7.4) at 4◦C. For rab-
bit sera antibodies, blood samples were kept overnight at room
temperature, sera were separated by centrifugation and thereafter
stored at −20◦C until use. IgG was precipitated with ammonium
sulphate (45% saturation) and stirred overnight at 4◦C. After cen-
trifugation at 10,000 × g for 3min at 4◦C, supernatants were
discarded and pellets were dissolved and dialyzed against PBS
(pH 7.4). The specificity and titer of the antibodies was checked
against Stx2B recombinant protein by Dot Blot and Western Blot
assays. Also, the cytotoxin-neutralizing activity of anti-Stx2B IgY
and IgG antibodies was assessed by incubation of 4 CD50 of the
holotoxin with serial dilutions of the antibodies. Preimmune anti-
bodies were included as a negative control (Parma et al., 2011).
Anti-Stx2B IgG antibodies were conjugated to horseradish per-
oxidase by using EZ-Link Plus activated peroxidase (Thermo
Scientific).
TEST SAMPLES
The STEC strains analyzed in this study have been previously
described regarding the serotype, cytotoxicity and other viru-
lence factors (Parma et al., 2000; Padola et al., 2004; Sanz et al.,
2007; Krüger et al., 2011). The 42 STEC strains were selected in
order to include strains harboring different stx variants as well as
different origins (feedlot cattle, grazing cattle, cattle at abattoir,
ground beef, and hamburgers) (Table 1). To assess the specificity
of the anti-Stx2B IgY sandwich ELISA, non-STEC strains (23 iso-
lates) were also collected (Table 2). Supernatants were prepared
from the selected strains and tested by ELISA and Vero cell assay.
Briefly, bacterial cultures were grown at 37◦C in LB medium until
OD 600 nm reached 0.3. The culture was then supplemented with
mitomycin C (0.5μg/ml) and incubated overnight. Supernatants
were obtained by centrifugation of bacteria at 10,000 × g for
10min at 4◦C. Samples were filter-sterilized and stored in aliquots
at −20◦C.
PURIFICATION OF WILD TYPE Stx2 HOLOTOXIN
The supernatant of wild type Stx2 was prepared from strain
59-2 isolated from cattle (Parma et al., 2000) as in Section “Test
Samples.” This preparation was applied to the HiTrap NHS-
activated HP (GE) column coupled with affinity purified anti-
Stx2B IgG obtained as described previously (Parma et al., 2011).
The column was washed with binding buffer (75mM Tris-HCl
pH 8.0) until the absorbance (λ: 280 nm) of the wash solution
returned to baseline values. The Stx2 bound to the column was
eluted with three volumes of elution buffer (100mM glycine,
0.5M NaCl pH 2.7) in collection tubes and immediately neutral-
ized with 1 M Tris-HCl (pH 9.0). This procedure was repeated
three times and the fractions were pooled and concentrated using
an Amicon ultrafiltration unit fitted with an YM 10 membrane.
The purity and concentration of Stx2 holotoxin in the eluted frac-
tion were determined by SDS-PAGE. Briefly, recombinant Stx2B
(4.34μg), Stx2 supernatant and Stx2 in the eluate (13.5μl of
each one) were separated by 12.5% SDS-PAGE and stained with
Coomasie Blue. The percentage of purity and the concentration of
Stx2 were quantified by densitometry using NIH Image software
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Table 1 | STEC strains tested in this work.
Result
Stx genotype Serotype Vero cell Ridascreen-EIA IgY-ELISA
stx2EDL933 O91:H21 + 3+ +
stx2EDL933 O145:H– + 4+ +
stx2EDL933 O20:H19 + 4+ +
stx2EDL933 O145:H– + 4+ +
stx2EDL933 O145:H– + 4+ +
stx2EDL933 O113:H21 + 4+ +
stx2EDL933 O113:H21 + 4+ +
stx2EDL933 O26:H11 + 4+ +
stx2EDL933 O91:H21 + 2+ +
stx2EDL933 O39:H49 + 4+ +
stx2EDL933 ONT:H21 + 4+ +
stx2EDL933 O39:H49 + 4+ +
stx2EDL933 ONT:H19 + 4+ +
stx2EDL933 O145:H– + 4+ +
stx2EDL933 O39:H49 + 4+ +
stx2EDL933 O39:H49 + 4+ +
stx2vha O113:H21 + 4+ +
stx2vha O162:H7 + 4+ +
stx2vha ONT:H21 + 4+ +
stx2vha ONT:H7 + 4+ +
stx2vha O113:H21 + 1+ +
stx2vha O171:H2 + 2+ +
stx2vha O117:H7 + 4+ +
stx2vha O178:H19 + 1+ +
stx2vhb O91:H21 + 1+ +
stx2vhb O20:H19 + 3+ +
stx2vhb O79:H19 + 4+ +
stx2vhb O174:H21 + 4+ +
stx2vhb O2:H– + 2+ +
stx2vhb O171:H– + 4+ +
stx2vhb O117:H7 + 2+ +
stx2vhb O171:H2 + 4+ +
stx2g O15:H21 + − +
stx2g O175:H8 + − +
stx2g O175:H8 + − +
stx2g O2:H25 + 4+ +
stx1EDL933 O174:H21 + 4+ +
stx1EDL933 O8:H16 + 4+ +
stx1EDL933 O5:H– + 4+ +
stx1EDL933 O145:H– + 4+ +
stx1EDL933 O26:H11 + 4+ +
stx1d ONT:H8 + 1+ +
(Image J). Then, proteins were transferred from SDS-PAGE to
nitrocellulose membrane (Hybond ECL, Amersham Pharmacia
Biotech) blocked overnight at 4◦C with 5% skimmed milk in
PBS-T 0.1% and incubated with a 1:200 dilution of anti-Stx2B
IgY in PBS-T for 1 h at 37◦C. After washing, the membrane
was incubated with horseradish peroxidase-conjugated goat anti-
chicken IgY (1:4000) for 1 h at 37◦C. Finally, membrane was
revealed using DAB/H2O2 system. The integrity and biological
activity of the holotoxin was checked by ELISA andVero cell assay,
respectively.
Table 2 | Non-STEC strains tested in this work.
Result
Strain Vero cell IgY-ELISA
Proteus mirabilis − −
Proteus vulgaris − − ‘
Morganella morganii − −
Citrobacter freundii − −
Enterococcus faecalis − −
Campylobacter coli − −
Shigella flexneri − +
Shigella sonnei − −
Campylobacter jejuni − −
Staphylococcus aureus − −
Enterobacter cloacae − −
Salmonella typhimurium 09/63 − −
Salmonella typhimurium 09/67 − −
Salmonella enteritidis PT II − +
Salmonella gallinarum 1982 − −
Klebsiella pneumoniae − −
Clostridium difficile − −
Clostridium perfringens tipo D − −
Clostridium perfringens − −
Clostridium perfringens tipo A − −
E. coli DH5 α − −
Enteropathogenic E. coli − −
E. coli XL1 − −
ANTI-Stx2B IgY SANDWICH ELISA
Microplates (Nunc, Maxisorp) were coated overnight at 4◦C
with a 1:500 dilution of specific IgY antibodies in carbon-
ate/bicarbonate buffer pH 9.6. After washing with PBS-T 0.05%,
plates were blocked with 5% skimmed milk in PBS-T for 1 h
at 37◦C. Culture supernatants were diluted 1:5 in PBS-T and
incubated at 37◦C for 1 h. Plates were washed and then incu-
bated with a 1:500 dilution of horseradish peroxidase-conjugated
anti-Stx2B IgG antibodies in 5% skimmed milk -PBS-T. Plates
were incubated 1 h at 37◦C, and after washing developed with
TMB (Sigma)/peroxidase substrate solution. The reaction was
stopped with 2 N H2S04 and absorbance was read at 450 nm.
Stx2-containing supernatant from strain 59-2 was used as a
positive control. A non-STEC E. coli DH5α supernatant was
included as a negative control. All samples were processed by
duplicate.
Receiver operating characteristic (ROC) curve analysis
(MedCalc Software 8.1.0.0) was performed on the ELISA results
to determine the optimal cut-off point (at which the sum of the
sensitivity and specificity values is highest) for distinguishing
between positive and negative results. Specimens were considered
Shiga toxin positive when the optical density was >0.26. Test
results were recorded as positive (+) or negative (−). The
detection limit was determined with twofold serial dilutions of
the purified Stx2 holotoxin and calculated from the mean + 3 SD
of the blank control. The intra-assay test was performed using
three different culture supernatants (with high, medium, and
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low OD values), in replicates of six across the microplate.
The inter-assay test was performed using three different culture
supernatants (with high, medium, and low OD values) in dupli-
cates repeated on three different microplates on different days.
Coefficients of variation were calculated for each sample as the
SD/mean × 100.
THE RIDASCREEN-EIA
This assay (Ridascreen® Verotoxin, R-Biopharm, Germany) is
provided as a kit containing a microtitre plate coated with mouse
monoclonal antibodies directed against Stx1 and Stx2, as well as
enzyme-conjugate, washing buffer, enzyme substrate, and stop
solution. The assay was performed following the instructions of
the manufacturer (http://www.r-biopharm.de/). Inactivated Stx
is provided as positive and non-inoculated growth medium was
taken as negative control. The cut-off value for recording results
as positive was calculated by adding 0.1 OD to the value obtained
with the negative control as described for the Ridascreen-EIA.
Test results were recorded as weak (1+) positive if the extinc-
tion was >0.1–0.5 above the negative control, moderate (2+)
(extinction >0.5–1.0 above negative control), strong positive
3+ (>1.0–2.0) to 4+ (>2.0) and negative (−).
CYTOTOXICITY TEST
African green monkey kidney (Vero) cells were plated at 104/well
on 96-well plates in Dulbecco’s Modified EagleMedium (DMEM)
containing 10% fetal bovine serum and incubated overnight at
37◦C under 5% CO2. Serial twofold dilutions of STEC super-
natants in DMEM medium were prepared. Non-STEC super-
natants were also included in order to discard the presence of
Stx in species other than E. coli. Dilutions were added to the cell
monolayer (100μl/well) and incubated for 48 h at 37◦C under 5%
CO2. The viability of the Vero cells was determined by crystal vio-
let staining (Gentry and Dalrymple, 1980). All data represent the
average of triplicate assays.
RESULTS
IgY AND IgG ANTIBODY YIELD
Highly purified total antibodies preparations were obtained from
rabbit sera and chicken egg yolk by the ammonium precipitation
method. The final concentration of total IgY was 0.84mg/ml of
egg yolk (equivalent to 8.4mg of total IgY per egg). The con-
centration of total IgG was 1.35mg/ml of sera. Both polyclonal
antibodies, IgY and IgG neutralized the cytotoxic effects of Stx2
holotoxin on Vero cells. However, IgG antibodies were four times
more efficient than IgY antibodies, since 1.09μg/ml were suf-
ficient to neutralize the effect of the toxin in vitro, compared
with IgY antibodies that obtained the same effect with 4.38μg/ml
(Parma et al., 2011).
PURIFICATION OF Stx2 HOLOTOXIN
Densitometry analysis of the band patterns obtained by SDS-
PAGE, showed approximately a 20% purity of the Stx2 in the
eluate (Figure 1, lane 2) representing an enrichment of 50% com-
pared with the Stx2 in the supernatant of strain 59-2 (Figure 1,
lane 3). Band intensity corresponding to the 2B subunit from
Stx2 in the eluate (Figure 1, lane 2) was compared with the
one produced by a known amount of 2B recombinant protein
(Figure 1, lane 1) using NIH Image software (Image J). We con-
cluded that the concentration of Stx2 in the eluted fraction was
around 75μg/ml. In addition, the purification procedure pre-
served the biological activity of the holotoxin, as this solution was
cytotoxic on Vero cell monolayer.
DETERMINATIONOF THE DETECTION LIMIT AND THE
REPRODUCIBILITY OF ANTI-Stx2B IgY SANDWICH ELISA
Serial twofold dilutions of purified Shiga toxin were tested by
the IgY sandwich ELISA to evaluate its sensitivity (Figure 2).
The ELISA developed was able to detect 115 ng/ml of purified
wild type Stx2. A good dose-response correlation was observed
between 0.93 and 7.5μg of toxin per ml.
FIGURE 1 | Analysis of Stx2 holotoxin by SDS-PAGE and Western blot.
(A) SDS-PAGE (12.5% acrylamide, under reducing conditions)
Lane 1: Purified recombinant Stx2B (4.34μg) Lane 2: Stx2 holotoxin in the
eluate (13.5μl) Lane 3: Stx2 supernatant from strain 59-2 (13.5μl). Gel was
stained with Coomassie Blue. (B) Western blot Lane 1: Purified recombinant
Stx2B (4.34μg) Lane 2: Stx2 holotoxin in the eluate (13.5μl) Lane 3: Stx2
supernatant from strain 59-2 (13.5μl). Membrane was incubated with
anti-Stx2B IgY and anti-IgY HRP. Arrow: Stx2B subunit position.
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FIGURE 2 | Titration curve of purified Stx2 by anti-Stx2B IgY sandwich
ELISA. The reaction was carried out using anti-Stx2B IgY followed by serial
twofold dilutions of purified Stx2 and incubation with horseradish
peroxidase-conjugated anti-Stx2B IgG. The detection limit was calculated
from the mean + 3 SD of the blank control.
Coefficients of variation among the wells (intra-assay) ranged
from 5.5 to 5.7% and coefficients of variation among the plates
(inter-assay) ranged from and 3.2 to 7.7%.
COMPARISON OF THE PERFORMANCE OF IgY-ELISA,
RIDASCREEN EIA AND VERO CELL ASSAY FOR THE DETECTION
OF SHIGA TOXINS
The IgY-ELISA assay detected all stx gene variants tested in this
work: stx2EDL933, stx2vha, stx2vhb, stx2g, stx1EDL933, stx1d (Table 1),
although IgY antibodies were prepared by immunization with
recombinant Stx2B obtained from a stx2EDL933 variant. These
samples were collected from STEC strains of various serotypes
and origins. The positive results in the IgY-ELISA were in accor-
dance to those of the Vero cell assay and the Ridascreen-EIA, with
the exception of three samples containing the stx2g variant, which
were negative in the Ridascreen-EIA.
Only two supernatants from a total of 23 non-STEC samples
showed an OD above the cut off. These samples were negative for
cytotoxicity on the Vero cell assay (Table 2).
RELATIVE SENSITIVITY AND SPECIFICITY OF THE IgY-ELISA
The relative sensitivity and specificity were determined consid-
ering the cut off value calculated by an interactive dot diagram
(MedCalc Software 8.1.0.0) that divided the population into
Stx-positive and Stx-negative strains (Figure 3). The relative sen-
sitivity was defined as the number of positive strains in the assay
divided by the total number of STEC strains, and resulted in
100% for the IgY-ELISA compared with 92.8% obtained with
Ridascreen-EIA.
The relative specificity, defined as the number of negative
strains in the assay divided by the total number of non-STEC
strains, showed a percentage for IgY-ELISA of 91.3.
DISCUSSION
Chickens, as a host for the production of egg yolk antibod-
ies against E. coli Stx2B, showed a remarkable ability to rapidly
and efficiently generate an abundant supply of high-titer anti-
body, which is able to bind to the wild type holotoxin and also
to neutralize their biological activity both in vitro and in vivo
(Parma et al., 2011). The present report describes a sensitive
antigen capture-ELISA for Shiga toxin which is based on antibod-
ies produced in chicken and rabbits immunized with a purified
non-toxic recombinant Stx2B subunit. All STEC strains tested in
this work, which produced Stx (as confirmed by the Vero cell
assay) were specifically recognized in the IgY-ELISA, although
they belong to different origins and serotypes. One disadvantage
of ELISA assays are false positives, in this case IgY antibodies
recognized 2/23 non-STEC supernatants, one from Salmonella
enteritidis and another from Shigella flexneri which showed neg-
ative results on Vero cell assay. Non-STEC supernatants were
included in the cytotoxicity assay because it has been reported
that other members of the family Enterobacteriaceae are known
FIGURE 3 | Interactive dot diagram (MedCalc Stadistical Software).
In the graph the data of the Stx-positive and Stx-negative strains are
displayed as dots on two vertical axes. A horizontal line indicates the cut-off
point with the best separation (minimal false negative and false positive
results) between the two groups. The corresponding test characteristics
sensitivity and specificity are shown at the right side of the graph.
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to produce Stx and to cause serious gastrointestinal disease and
HUS in humans (Paton and Paton, 1998). S. dysenteriae type
1, the causative agent of bacillary dysentery, is the principal
cause of HUS in parts of Africa and Asia (Azim et al., 1997;
Bhimma et al., 1997). Stx2-producing Citrobacter freundii also
causes diarrhea and HUS in humans, including one outbreak in
a German child care centre (Schmidt et al., 1993; Tschäpe et al.,
1994). Enterobacter cloacae has also been associated with tran-
sient expression of an stx2-related gene, although its role in disease
is unproven (Paton and Paton, 1996). In addition, samples con-
taining Staphylococcus aureus can produce false positives in the
ELISA since protein A binds the Fc region of IgG antibodies. This
interference is not observed with IgY antibodies since they do not
recognize this protein (Mizutani et al., 2012). This fact was con-
firmed in our lab when we run an ELISA assay with a S. aureus
supernatant, where IgG instead of IgY was coated to the plate
(data not shown).
Several ELISAs employed monoclonal antibodies, such as
the Ridascreen-EIA (R-Biopharm AG, Germany) and Premier
EHEC assay (Meridian Diagnostics Inc.) to improve the speci-
ficity and reduce false positives. Monoclonal antibodies being
directed against single epitopes are homogeneous, highly specific
and can be produced in unlimited quantities. However, producing
a high quality monoclonal antibody is often difficult, laborious
and expensive. Polyclonal antibodies present some advantages
compared to monoclonal antibodies, as they recognize multi-
ple epitopes on the antigen, so they become more tolerant to
minor changes on their structure. Their production is relatively
inexpensive, the technology and skills required for production
are low, and the production time scale is comparatively short.
However, the use of polyclonal antibodies has certain limitations
such as batch to batch variation, inconsistent yields of antibod-
ies and scanty serum obtained from individual animals. The IgY
derived from hyperimmune chicken egg yolk has been recog-
nized as an excellent, alternative source of polyclonal antibodies
(Hodek and Stibororá, 2003). A single chicken can produce an
enormous amount of antibody, up to 3 g of IgY per month, which
is 10–20 times the amount of a rabbit (Mine and Kovacs-Nolan,
2002). Furthermore, compared to rabbits, chickens produce anti-
bodies in shorter time periods given that high-titer antibodies
can be available from eggs as early as day 25. To our knowl-
edge, it is the most humane way to produce polyclonal antibodies
because there is no need to bleed the chicken, simply collecting
the eggs. In addition, we have previously described (Parma et al.,
2011) that the same amount of specific anti-Stx2B antibodies can
be obtained from five eggs yolks than from the exsanguination
of one rabbit.
Analyzing mitomycin C treated cultures, we determined a
relative sensitivity of 100% for the IgY-ELISA, with a detec-
tion limit of around 115 ng/ml. Law et al. (1992) described that
mitomycin C enhanced the yield of Shiga toxins in O157:H7
cultures about 100-fold compared with growth without mito-
mycin C. This group also described an ELISA with a detection
limit of around 1.6 ng/ml. In this case, plates were coated with
crude hydatid cyst material and toxins were detected adding spe-
cific rabbit antibodies and revealed with anti-rabbit conjugated
to alkaline phosphatase. Kongmuang et al. (1987) developed a
sandwich ELISA for Shiga toxin detection, using antibodies from
rabbits immunized with the complete inactivated toxin. This
ELISA also detected several nanograms of purified Shiga toxin per
milliliter. The Premier EHEC assay was found to bemore sensitive
than conventional sorbitol-Mac Conkey culture for the detection
of E. coli O157:H7 (100 and 60%, respectively) (Sue Kehl et al.,
1997). Beutin et al. (2007) evaluated the suitability of Ridascreen-
EIA for detection of Stx1, Stx2, and their variants with STEC
reference strains and STEC isolates from sources such as food,
human feces, surface water, and animal feces, resulting in a rel-
ative sensitivity and specificity of 95.7 and 98.7%, respectively.
However, this assay was less applicable for testing samples where
low amounts of Stx are expected, such as mixed cultures or pres-
ence of stx2g variant. This fact was also observed in our work, were
IgY-ELISA could detect all STEC containing stx2g variant while
Ridascreen-EIA only showed positive in one of four cases.
In STEC infections, a rapid diagnosis is necessary in order
to establish a proper supportive treatment. In many laborato-
ries, diagnosis is made by fecal culture on sorbitol-Mac Conkey
agar to isolate strains of E. coli serotype O157:H7 which are
sorbitol non-fermenters, followed by agglutination with specific
antisera. However, several drawbacks limit the utility of culture,
including slow turnaround, false negative results in antibiotic-
treated patients, and false STEC negative results due to emerging
serotypes of non-O157 STEC that ferment sorbitol (Bettelheim,
1998). Although, Vero cell assay is more sensitive than ELISA,
with detection limits of around picograms per milliliter of toxin
(Kongmuang et al., 1987) this assay requires that specificity of
any cytotoxic activity be confirmed with appropriate neutraliz-
ing antibodies. In addition, it is a time-consuming and expensive
technique. It is however essential for reference laboratories to
continue to use this test, because it will reveal the presence
of unknown variants of Stxs (Bettelheim and Beutin, 2003).
ELISAs do offer relative speed, greater availability, are suitable for
large-scale screening, and easily applicable in routine diagnostic
laboratories without the need for expensive equipment.
The results of this study indicate that polyclonal IgY antibodies
anti-Stx2B are a useful alternative to detect most of the vari-
ants of Shiga toxin among supernatant cultures of STEC strains
belonging to different serotypes. Although further studies with
clinical samples must be done, we propose the use of polyclonal
IgY antibodies in order to reduce the cost of the assay in compar-
ison to commercial kits that include monoclonal antibodies. EIA
and other quick non-culture tests are useful tools for diagnosis of
STEC infection, constituting an important complement to micro-
biological, molecular characterization and serological methods
for detecting and controlling STEC outbreaks (CDC, 2009).
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